Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q1 2023 vs. Q4 2022
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 12 | 11 | −1 |
| Shares | 228.8K | 334.9K | +106.0K (+46.3%) |
| Value | $248.8K | $1.31M | +$1.06M (+426.3%) |
New holders (7)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 74,284 | $290.4K | 0.00% |
| Vanguard Group Inc | 64,022 | $250.3K | 0.00% |
| State Street Corp | 41,700 | $163.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 40,500 | $158.4K | 0.00% |
| Bank of America Corp | 15,000 | $58.6K | 0.00% |
| Wolverine Asset Management LLC | 1,538 | $6.01K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,304 | $5.00K | 0.00% |
Sold out (8)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Polar Asset Management Partners Inc. | 25,698 | $27.2K |
| Susquehanna International Group, LLP | 23,646 | $26.2K |
| D. E. Shaw & Co., Inc. | 20,077 | $22.3K |
| Yakira Capital Management, Inc. | 20,757 | $22.0K |
| Context Capital Management, LLC | 16,278 | $17.0K |
| Boothbay Fund Management, LLC | 13,572 | $14.4K |
| Atw Spac Management LLC | 13,572 | $14.4K |
| Morgan Stanley | 3 | $3 |